• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Illustration of stacked gold coins with a hand placing another coin on top set against an upward-trending red arrow and stoc
Special Reports

Big Pharma's 10 highest-paid CEOs of 2025

Fierce is finishing the 2025 tally by laying out the annual rankings of the top-paid CEOs among the industry's heavyweight companies.
Fraiser Kansteiner , Kevin Dunleavy , Zoey Becker , Eric Sagonowsky Jun 16, 2026 3:00am
ASCO 2026 showed that precision oncologys next challenge is translation

Precision oncology’s next challenge is translation

Brought to you by Thermo Fisher Scientific
Sign on doorway for FTC in Washington DC

Aurobindo must divest 4 drugs to complete Lannett buyout: FTC

Jun 18, 2026 3:45pm
The legacy approach to real-world data is costing you

The legacy approach to real-world data is costing you

Brought to you by HealthVerity
Food and Drug Administration

Regulatory tracker: FDA approves expansion for Merck's Capvaxive

Jun 18, 2026 2:15pm
European Commission Approves CinnaGens Zandoriah teriparatide biosimilar for Osteoporosis in Adults

European Commission Approves CinnaGen’s Zandoriah (teriparatide)

Brought to you by CinnaGen
More News

Pfizer's CFO Dave Denton plans August departure

Jun 18, 2026 11:50am

'Familiarity' with oral Wegovy has triggered its quick uptake

Jun 18, 2026 11:15am
Fierce Healthcare

Eli Lilly cuts hospitals' 340B pricing over data policy dispute

Jun 18, 2026 11:00am

Cellares, Ori dominate automated cell therapy production: report

Jun 18, 2026 10:10am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings